A Joint Position Statement by Malaysian Paediatric Association, Academy of Medicine of Malaysia College of Paediatrics and Malaysian Society of Paediatric Gastroenterology, Hepatology and Nutrition in Reaffirming the Universal Hepatitis B Birth Dose in Malaysia
Malaysian Journal of Paediatrics and Child Health · 20.04.2026 · 32 (1) · 1-7
DOI: 10.51407/mjpch.v32i1.442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Malaysian Journal of Paediatrics and Child Health, online erschienen am 20.04.2026. Verfasst von Erwin Khoo Jiayuan und 8 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In late 2025, the United States Centers for Disease Control and Prevention shifted from a universal hepatitis B birth dose recommendation to a risk-based framework. This statement reaffirms the critical importance of maintaining Malaysia’s universal 24-hour birth dose policy within its National Immunisation Programme. Main Text: Malaysia’s universal birth dose, introduced in 1989, has been a monumental public health success, reducing childhood HBV surface antigen prevalence to ~0.3%. Abandoning this policy would jeopardise decades of progress. The universal approach acts as an essential “vaccine safety net”, protecting against systemic failures in antenatal screening, documentation, and care coordination that a risk-based strategy cannot overcome. Immunologically, the birth dose is crucial due to the neonatal vulnerability to chronic infection. The policy is also highly cost-effective and grounded in principles of equity and justice, ensuring protection for all newborns regardless of socioeconomic or geographic factors. Strengthening complementary measures, such as universal antenatal screening and digital health records, is encouraged.
Conclusions
The Malaysian Paediatric Association, the Academy of Medicine of Malaysia College of Paediatrics, and the Malaysian Society of Paediatric Gastroenterology, Hepatology and Nutrition unanimously urge Malaysia to maintain its universal HBV birth dose. This policy remains a fundamental, non-negotiable pillar of child health and hepatitis B elimination efforts in the national context.
Zitieren
APA
Jiayuan, E. K., Hamid, I. J. A., Nordin, M. M., Ismail, Z., Ng, D. C., Thong, M., Cheah, F. C., Khoh, A., & Lee, W. S. (2026). A Joint Position Statement by Malaysian Paediatric Association, Academy of Medicine of Malaysia College of Paediatrics and Malaysian Society of Paediatric Gastroenterology, Hepatology and Nutrition in Reaffirming the Universal Hepatitis B Birth Dose in Malaysia. Malaysian Journal of Paediatrics and Child Health, 32(1), 1-7. https://doi.org/10.51407/mjpch.v32i1.442
Vancouver
Jiayuan EK, Hamid IJA, Nordin MM, Ismail Z, Ng DC, Thong M, et al. A Joint Position Statement by Malaysian Paediatric Association, Academy of Medicine of Malaysia College of Paediatrics and Malaysian Society of Paediatric Gastroenterology, Hepatology and Nutrition in Reaffirming the Universal Hepatitis B Birth Dose in Malaysia. Malaysian Journal of Paediatrics and Child Health. 2026;32(1):1-7. doi:10.51407/mjpch.v32i1.442
BibTeX
@article{Jiayuan2026,
author = {Jiayuan, Erwin Khoo and Hamid, Intan Juliana Abd and Nordin, Musa Mohd and Ismail, Zulkifli and Ng, David Chun-Ern and Thong, Meow-Keong and Cheah, Fook Choe and Khoh, Alvin and Lee, Way Seah},
title = {A Joint Position Statement by Malaysian Paediatric Association, Academy of Medicine of Malaysia College of Paediatrics and Malaysian Society of Paediatric Gastroenterology, Hepatology and Nutrition in Reaffirming the Universal Hepatitis B Birth Dose in Malaysia},
journal = {Malaysian Journal of Paediatrics and Child Health},
year = {2026},
volume = {32},
number = {1},
pages = {1--7},
doi = {10.51407/mjpch.v32i1.442}
}
EUVIMED